MENU

PVLA Palvella Therapeutics Inc Forecast, Technical & Fundamental Analysis

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies... Show more

PVLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
PVLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PVLA is expected to report earnings to fall 3.33% to -115 cents per share on August 13

Palvella Therapeutics Inc PVLA Stock Earnings Reports
Q2'26
Est.
$-1.16
Q1'26
Missed
by $0.71
Q4'25
Beat
by $0.04
Q3'25
Beat
by $1.10
Q2'25
Beat
by $1.17
The last earnings report on May 07 showed earnings per share of -120 cents, missing the estimate of -49 cents. With 36.76K shares outstanding, the current market capitalization sits at 1.70B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LNGX40.750.82
+2.06%
Global X U.S. Natural Gas ETF
ZAPR26.59-0.01
-0.04%
Innovator Equity Dfnd Prt ETF -1 Yr Apr
FOCT52.15-0.08
-0.15%
FT Vest US Equity Buffer ETF Oct
NPV11.38-0.03
-0.26%
Nuveen Virginia Quality Municipal Income Fund
CUT27.80-0.17
-0.62%
Invesco MSCI Global Timber ETF

PVLA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PVLA has been loosely correlated with DRMA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PVLA jumps, then DRMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVLA
1D Price
Change %
PVLA100%
+5.08%
DRMA - PVLA
42%
Loosely correlated
+5.13%
VIR - PVLA
41%
Loosely correlated
+4.48%
IOVA - PVLA
38%
Loosely correlated
+3.84%
ARQT - PVLA
37%
Loosely correlated
+1.76%
SEPN - PVLA
35%
Loosely correlated
-3.70%
More
Palvella Therapeutics (PVLA) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com